tergene.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Home | Tergene |
| Description | Tergene Biotech is one of the innovative biotechnology companies engaged in the development of vaccines such as Pneumococcal Conjugate Vaccine and |
| Keywords | vaccine, pneumonia, pneumococcal conjugate vaccine, pneumococcal, crm197, crm 197, carrier protein, glycoconjugate, human vaccine, protect, children, 15 valent, pneuteger |
Server Information
| WebSite | |
| Host IP | 143.95.79.232 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
tergene.com Valuation
|
US$1,737
Last updated: 2023-05-03 17:13:12
tergene.com has Semrush global rank of 0. tergene.com has an estimated worth of US$ 1,737, based on its estimated Ads revenue. tergene.com receives approximately 200 unique visitors each day. Its web server is located in United States, with IP address 143.95.79.232. According to SiteAdvisor, tergene.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,737 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$48 |
| Yearly Ads Revenue | US$577 |
| Daily Unique Visitors | 13 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| tergene.com. | A | 3599 | IP: 143.95.79.232 |
| tergene.com. | NS | 3600 | NS Record: ns2.accountservergroup.com. |
| tergene.com. | NS | 3600 | NS Record: ns1.accountservergroup.com. |
| tergene.com. | MX | 3600 | MX Record: 10 tergene.com. |
HtmlToTextCheckTime:2023-05-03 17:13:12
| --> About Contact Previous Next --> News Affordable Vaccine platform March 2014 Promoted by scientist- turned entrepreneur, Tergene Biotech has made a mark in a short period of time. The company is envisioned to provide quality human biologics. BIRAC Innovators Award 2013 Dr. M. Kuppusamy receiving the DBT - BIRAC Innovator Award from Dr. G. Padmanaban, Advisor, Department of BioTechnology, Govt. of India and Dr. K. Vijayraghavan, Secretary, DBT. Biospectrum Magazine Nov 2011 With funding from BIPP, Tergene initiated a project to develop an indigenous vaccine to tackle pneumonia that kills more children under the age of five than any other disease. Areas of work Thrombolytic enzymes Glyco-conjugates Pneumococcal Conjugate Vaccine CRM197 carrier protein BTA Environment, Health and Safety © 2022 Tergene Biotech Ltd. All rights reserved. |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Mon, 25 Oct 2021 22:09:57 GMT Server: Apache Location: http://www.tergene.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Mon, 25 Oct 2021 22:09:58 GMT Server: Apache Upgrade: h2,h2c Connection: Upgrade Last-Modified: Sun, 03 May 2020 11:06:48 GMT Accept-Ranges: bytes Content-Length: 9114 Vary: Accept-Encoding Content-Type: text/html |
tergene.com Whois Information
Domain Name: TERGENE.COM Registry Domain ID: 1244775027_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2021-08-30T05:38:09Z Creation Date: 2007-09-28T11:04:14Z Registry Expiry Date: 2022-09-28T11:04:14Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: DNS.SITE5.COM Name Server: DNS2.SITE5.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-14T00:15:05Z <<< |